Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms
Clinical trial NCT05316480 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05316480
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2025-04-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.